129 related articles for article (PubMed ID: 35007526)
1. Cathepsin B is a potential therapeutic target for coronavirus disease 2019 patients with lung adenocarcinoma.
Ding X; Ye N; Qiu M; Guo H; Li J; Zhou X; Yang M; Xi J; Liang Y; Gong Y; Li J
Chem Biol Interact; 2022 Feb; 353():109796. PubMed ID: 35007526
[TBL] [Abstract][Full Text] [Related]
2. Identification of angiotensin-converting enzyme 2 (ACE2) protein as the potential biomarker in SARS-CoV-2 infection-related lung cancer using computational analyses.
Samad A; Jafar T; Rafi JH
Genomics; 2020 Nov; 112(6):4912-4923. PubMed ID: 32916258
[TBL] [Abstract][Full Text] [Related]
3. Expression of SARS-COV-2 cell receptor gene ACE2 is associated with immunosuppression and metabolic reprogramming in lung adenocarcinoma based on bioinformatics analyses of gene expression profiles.
Uddin MN; Akter R; Li M; Abdelrahman Z
Chem Biol Interact; 2021 Feb; 335():109370. PubMed ID: 33422520
[TBL] [Abstract][Full Text] [Related]
4. Expression and Clinical Significance of SARS-CoV-2 Human Targets in Neoplastic and Non-Neoplastic Lung Tissues.
Subbarayan K; Ulagappan K; Wickenhauser C; Seliger B
Curr Cancer Drug Targets; 2021 Jul; 21(5):428-442. PubMed ID: 33292131
[TBL] [Abstract][Full Text] [Related]
5. Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors.
Radzikowska U; Ding M; Tan G; Zhakparov D; Peng Y; Wawrzyniak P; Wang M; Li S; Morita H; Altunbulakli C; Reiger M; Neumann AU; Lunjani N; Traidl-Hoffmann C; Nadeau KC; O'Mahony L; Akdis C; Sokolowska M
Allergy; 2020 Nov; 75(11):2829-2845. PubMed ID: 32496587
[TBL] [Abstract][Full Text] [Related]
6. FURIN correlated with immune infiltration serves as a potential biomarker in SARS-CoV-2 infection-related lung adenocarcinoma.
Luo L; Li M; Su J; Yao X; Luo H
Clin Exp Med; 2022 Aug; 22(3):371-384. PubMed ID: 34510311
[TBL] [Abstract][Full Text] [Related]
7.
Hu S; Hu Z; Qin J; Lin C; Jiang X
Aging (Albany NY); 2021 Jun; 13(12):15770-15784. PubMed ID: 34168096
[TBL] [Abstract][Full Text] [Related]
8. Structural variations and expression profiles of the SARS-CoV-2 host invasion genes in lung cancer.
Ilikci Sagkan R; Akin-Bali DF
J Med Virol; 2020 Nov; 92(11):2637-2647. PubMed ID: 32492203
[TBL] [Abstract][Full Text] [Related]
9. Genomic, epigenomic, and immune subtype analysis of CTSL/B and SARS-CoV-2 receptor ACE2 in pan-cancer.
Li H; Xie L; Chen L; Zhang L; Han Y; Yan Z; Guo X
Aging (Albany NY); 2020 Nov; 12(22):22370-22389. PubMed ID: 33231569
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment.
Yu L; Cao S; Li J; Han B; Zhong H; Zhong R
Int Immunopharmacol; 2021 Sep; 98():107734. PubMed ID: 34175738
[TBL] [Abstract][Full Text] [Related]
11. Heat shock factor 5 correlated with immune infiltration serves as a prognostic biomarker in lung adenocarcinoma.
Aizemaiti R; Wu Z; Tang J; Yan H; Lv X
Int J Med Sci; 2021; 18(2):448-458. PubMed ID: 33390814
[TBL] [Abstract][Full Text] [Related]
12. Lung adenocarcinoma patients have higher risk of SARS-CoV-2 infection.
Chen L; Liu Y; Wu J; Deng C; Tan J; Liu H; Zhong L
Aging (Albany NY); 2021 Jan; 13(2):1620-1632. PubMed ID: 33429366
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level.
Wang W; Ren S; Wang Z; Zhang C; Huang J
Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma.
Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ
Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085
[No Abstract] [Full Text] [Related]
15. Network Pharmacology and Bioinformatics Analysis Identifies Potential Therapeutic Targets of Paxlovid Against LUAD/COVID-19.
Zhang W; Yang Z; Zhou F; Wei Y; Ma X
Front Endocrinol (Lausanne); 2022; 13():935906. PubMed ID: 36157452
[TBL] [Abstract][Full Text] [Related]
16. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
[TBL] [Abstract][Full Text] [Related]
17. Elevated expression of
Feng Z; Zhang J; Zheng Y; Wang Q; Min X; Tian T
Per Med; 2021 Mar; 18(2):115-127. PubMed ID: 33576264
[No Abstract] [Full Text] [Related]
18. Combination of tumor mutation burden and immune infiltrates for the prognosis of lung adenocarcinoma.
Zhao Z; He B; Cai Q; Zhang P; Peng X; Zhang Y; Xie H; Wang X
Int Immunopharmacol; 2021 Sep; 98():107807. PubMed ID: 34175739
[TBL] [Abstract][Full Text] [Related]
19. Low expression of NLRP1 is associated with a poor prognosis and immune infiltration in lung adenocarcinoma patients.
Shen E; Han Y; Cai C; Liu P; Chen Y; Gao L; Huang Q; Shen H; Zeng S; He M
Aging (Albany NY); 2021 Mar; 13(5):7570-7588. PubMed ID: 33658393
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection.
Kong Q; Xiang Z; Wu Y; Gu Y; Guo J; Geng F
Mol Cancer; 2020 Apr; 19(1):80. PubMed ID: 32345328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
